Sign in now to see personalised content appear here.
You can also see your reading history and subscription details on your subscriber page.
Will create a leading pharma firm with a portfolio of branded and generic medicines and a strong portfolio of over-the-counter products
Has the capacity to offer absolute protection for more than eight million samples
As the number of biological drugs increases, more careful consideration of packaging is required to ensure quality, safety and compliance. Susan Birks reports on the trends
Lonza will develop a cost-effective, scalable and robust suspension culture-based adenovirus manufacturing platform
Additional cleanroom space took less than 12 months from concept to completion and creates extra capacity
Prefilled syringes come in many varieties with the most fundamental difference being the material they are made of – glass or polymer. Manufacturer Schott considers how to make the right choice
Pfizer is the first pharmaceutical firm to join the programme
Protecting patients from product fraud and tampering has become a major industry and regulatory initiative. Justin Schroeder, Executive Director Marketing, Business Development and Design, PCI Pharma Services, summarises progress and highlights some unresolved issues
CTTV uses advances in genetic research and computational biology to help scientists with the crucial first step in exploring new medicines
Predictions of healthy growth in pharma outsourcing in 2015 seem to have been fulfilled, but can the trend be sustained this year? The latest surveys from Nice Insight suggest it can, writes Nigel Walker, Managing Director, That’s Nice LLC/Nice Insight
Increases the breadth of its services to meet client needs
It has long been known that pharmaceutical residues can become hormone-affecting ‘endocrine disrupters’ when released into the environment and future controls are likely – but how will the legislators tackle the issue? Manufacturing Chemist reports